Novo Nordisk taps new North American chief; Dr. Reddy's recalls antacid on bacterial contamination fears;

@FiercePharma: China's pharma probe intensifies with British consultant's arrest. ICYMI yesterday | Follow @FiercePharma

@CarlyHFierce: Check out Eli Lilly's statement on the latest bribery allegations in China. Article | Follow @CarlyHFierce

> Novo Nordisk ($NVO) installed Jesper Høiland as president of its North American unit; Høiland previously served as Novo's head of international operations. Release

> Indian generics maker Dr. Reddy's Laboratories recalled 3 lots of an antacid drug, ranitidine, after discovering that the raw material used to make it was contaminated with Pseudomonas bacteria. Report | More

> China's Shanghai Pharma announced a 3.7% increase in first-half net profits to 1.2 billion yuan, or about $195 million. Report

> If MannKind ($MNKD) succeeds in winning approval for its new inhaled insulin, that will be just the beginning of the challenges it faces in commercializing the drug. Report

> SkyePharma, which specializes in inhaled drugs, tapped Andrew Derodra as its new CFO. Release

Medical Device News

@FierceMedDev: Infraredx snags $25M as it sets sights on Japan. News | Follow @FierceMedDev

@DamianFierce: Bard settled another vaginal mesh lawsuit. That leaves about 7,999 to go. News | Follow @DamianFierce

@MarkHFierce: Why does Medtronic CEO Omar Ishrak tweet? Editor's corner | Follow @MarkHFierce

@MichaelGFierce: ICYMI... Study: Insulin pumps improve glycemic control in children with diabetes. Article | Follow @MichaelGFierce

> Chinese survey of device industry practices draws suspicion. News

> BioMérieux earns FDA's nod for novel Dx system. Story

> Cyberonics, a maker of neuromodulation devices, boosts sales in Q1. Item

Biotech News

@FierceBiotech: Popular yesterday: Incyte shares soar on positive pancreatic cancer trial data for Jakafi. Article | Follow @FierceBiotech

@JohnCFierce: FYI, we're adding a weekly diagnostics report to go along with our fast-growing med devices group of pubs. End of the month. Look for it. | Follow @JohnCFierce

@EmilyMFierce: Sodium 'switch' could provide target to treat brain disorders. Item | Follow @EmilyMFierce

> Analyst: Time to wrap up Amgen's $9.5B Onyx buyout. Story

> Regado misses IPO fiesta, limps into public spotlight with $43M raise. Article

> U.S./China biotech hybrid lands $25M to back global R&D strategy. Report

Vaccines News

> Sanofi delays return of vaccines after testing 'anomaly.' More

> GSK-backed study links flu vaccine to lower risk of heart attack. Report

> Improved vaccines mean flu immunization can start earlier. Story

> Vaccine refusers to miss out on tax benefits under Australian plan. Article

> India to investigate safety of pentavalent vaccines. More

Pharma Manufacturing News

@EricPFierce: Regeneron will turn an empty Dell computer plant in Ireland into its second manufacturing plant. Article | Follow @EricPFierce

> Dr. Reddy's recall affects Walmart, Walgreens, Supervalu. Item

> Doxycycline shortage shot in the arm for Hikma profits. More

> FDA not alone in acting on compounding pharmacies. Article

> Fresenius Kabi expands manufacturing in Indonesia with JV. Story

And Finally... A new study linked schizophrenia to a faulty brain "switch," leading to hopes of new drug-development appraoches. Report

Suggested Articles

AstraZeneca's Farxiga can help prevent worsening or death in heart failure patients regardless of other therapies received, according to new data.

Amid a tough fight in the blood thinner market, J&J and Bayer's Xarelto scored a trial win in treating PAD patients after a recent leg artery surgery.

Experts say it's worth exploring whether a Roche stroke drug could help certain COVID-19 patients.